Exscientia plc

Najat Khan has built her career at the intersection of drug development and technological innovation. As chief R&D and commercial officer at Recursion, she is helping to scale one of biotech’s (or

Pharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh

In the rapidly evolving landscape of pharmaceutical innovation, CHARM Therapeutics stands out as a pioneer in leveraging artificial intelligence (AI) to transform drug discovery. Founded by Laksh Aith

The number of financings among life sciences companies in the TechBio sector increased from Q3 2023, stabilizing in H1 2024. During the period Q3 2023 – Q3 2024, a total of $6bn was raised, with the s